# Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection

> **NCT00197418** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Hamamatsu University**

## Conditions studied

- Helicobacter Infections
- Gastritis
- Gastric Ulcer
- Duodenal Ulcer

## Interventions

- **DRUG:** rabeprazole, amoxicillin, clarithromycin, metronidazole

## Key facts

- **NCT ID:** NCT00197418
- **Lead sponsor:** Hamamatsu University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2006-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00197418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00197418, "Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00197418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*